GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture

Ethan M. Goldberg | Andreas M. Koupparis | W. C. Stewart | I. Scheffer | H. Stefánsson | H. Hakonarson | P. Derambure | P. May | Philip Smith | K. Yamakawa | M. Kanai | Y. Kamatani | Y. Okada | B. Neale | C. Elger | R. Kuzniecky | A. Schulze-Bonhage | B. Steinhoff | H. Kirsch | P. Sham | Í. Lopes-Cendes | M. Sperling | G. Cascino | A. Palotie | P. Striano | A. Coppola | C. Pato | M. Pato | J. Bradfield | L. Gjerstad | S. Schachter | S. Cherny | O. Devinsky | A. Marson | J. Shih | A. Beydoun | S. Sisodiya | U. Stephani | C. Barba | S. Berkovic | E. Vining | F. Rosenow | H. Stroink | N. Gupta | D. Howrigan | M. Kurki | L. Davis | S. Petrovski | Y. Lau | M. Nothnagel | C. Depondt | G. Cavalleri | F. Zara | B. Castellotti | R. Knowlton | A. Cole | E. Geller | E. Ólafsson | Manuela Pendziwiat | H. Muhle | I. Helbig | S. Knake | A. Lacey | M. Bahlo | S. Franceschetti | D. Kasperavičiūtė | N. Delanty | E. Heinzen | T. Pippucci | I. Najm | T. Bast | D. Speed | L. Valton | S. Schoch | Felecia Cerrato | C. Churchhouse | F. Zimprich | H. Hjalgrim | K. Klein | D. Lindhout | C. Doherty | A. Gambardella | R. Guerrini | R. Kälviäinen | A. Labate | D. Mei | R. Surges | M. Privitera | Wanling Yang | L. Brody | W. Kunz | T. Glauser | D. Dlugos | C. Cheung | Siwei Chen | Mitsuhiro Kato | F. Visscher | G. Sills | M. Feucht | B. Abou-Khalil | S. Magnússon | L. Baum | H. Krestel | B. Mostacci | P. Cossette | B. Kara | D. Kasteleijn-Nolst Trenité | Anja C. M. Sonsma | C. Schankin | B. Schmitz | B. Neubauer | T. Sander | E. Hirsch | T. Granata | F. Bisulli | L. Canafoglia | G. de Haan | Y. Inoue | K. Brockmann | P. Widdess-Walsh | R. Busch | J. Craig | H. Heyne | Z. Landoulsi | D. Greenberg | K. Haas | F. Chassoux | N. Bebek | L. Imbach | E. Taubøll | L. Licchetta | L. Di Vito | P. Tinuper | D. Andrade | L. Jehi | Judith L. Z. Weisenberg | H. Caglayan | J. Lemke | T. Linnankivi | S. Weckhuysen | L. Thio | P. Kwan | G. Kurlemann | M. Wolff | A. Molloy | S. Schubert-Bast | A. Poduri | A. Avbersek | R. Buono | C. Catarino | T. Ferraro | C. Leu | F. Becker | G. Tanteles | G. Lesca | Alison Anderson | M. Iacomino | M. Tsai | M. Rees | W. O. Pickrell | A. Strzelczyk | A. Vetro | S. Hirose | S. Papacostas | I. Krey | K. Chinthapalli | B. Baykan | P. Reif | M. Todaro | D. Turkdoğan | Philippe Ryvlin | D. Bobbili | G. Annesi | J. Eriksson | P. Auce | E. Parrini | M. Kanaan | A. Utkus | Jacqueline A. French | L. Sadleir | F. Fortunato | G. Kluger | K. Müller-Schlüter | S. Zagaglia | S. Balestrini | E. Freri | Viola Doccini | F. Ragona | Annika Rademacher | B. Koeleman | Christina Canavati | Z. Afawi | D. Lewis-Smith | A. van Baalen | M. Krenn | Martino Montomoli | C. Lui | A. Ishii | R. von Wrede | F. Madia | Ryan G. Wagner | S. Kariuki | Anne-Mari Kantanen | G. Balagura | W. Nasreddine | Brigid M. Regan | E. Campbell | J. Sander | Karen L. Oliver | B. Tumienė | Manu Hegde | I. Chou | J. Kegele | Stephanie L. Leech | E. Amadori | L. Muccioli | Chris M McGraw | Naomi Lewin | C. Stipa | I. Blatt | F. Pangilinan | T. Scattergood | Z. Yapıcı | M. Cosico | P. Hung | M. Baker | K. Tan | R. Stevelink | C. A. Bennett | G. Zsurka | S. Wolking | Christian Hengsbach | S. Rau | Anni Saarela | V. Braatz | Michael R. Johnson | Hany El-Naggar | R. Minardi | M. Gagliardi | C. Bianchini | Chontelle King | Pınar Topaloğlu | E. Yücesan | Y. Kesim | K. Hallmann | C. Boßelmann | A. Riva | G. Thomas | E. Hassanin | B. Berghuis | T. Giangregorio | P. Scudieri | N. Khoueiry-Zgheib | F. Bartolomei | J. Mills | Oskari Timonen | D. Lowenstein | M. Nöthen | F. Zahnert | Robert Powell | R. Tozzi | A. Korczyn | M. Fitzgerald | Charles R Newton | Federica Pondrelli | T. O'Brien | C. Cusick | O. M. Adesoji | Quratulain Zulfiqar Ali | B. Fonferko-Shadrach | Rebecca Pinsky | Sophie von Brauchitsch | B. Sheidley | Lisa Ferguson | R. Thomas | Albert Becker | C. Ellis | Peggy O. Clark | S. Chung | Peter Nürnberg | A. Franke | Michael Weller | Priya Vaidiswaran | Ingo Borggraefe | Annika B. Faucon | R. Krause | C. Campbell | Michael C. Smith | Rikke S. Møller | K. Stefánsson | P. Topaloğlu | A. Lehesjoki | Marcello Scala | Alicia Goldman | Ç. Özkara | Dennis Lal | U. Unnsteinsdóttir | J. Jamnadas‐Khoda | Qingqin S. Li | Y. A. Feng | Rodney Radtke | Kuang Lin | Lorenzo Ferri | Alastair Compston | M. J. Daly | I. Kousiappa | Y. Weber | H. Lerche | Tobias Baumgartner | Donald Hucks | Nasir Mirza | Joseph Anderson | Karen Barboza | Stephen Lauxmann | Gloria H.-Y. Li | Sylvain Rhelms | Toshimitsu Suzuki | R. Taneja | David Wu | Wei Zhou | L. Davis | Moien Kanaan | Albert J Becker | Dalia Kasperavičiūtė | Christopher M. McGraw | Birutė Tumienė | Jennifer Jamnadas-Khoda | Ilona Krey | Gloria H.-Y. Li | J. Weisenberg

[1]  K. Stefánsson,et al.  Polygenic risk score analysis reveals shared genetic burden between epilepsy and psychiatric comorbidities , 2023, medRxiv.

[2]  I. Scheffer,et al.  Genes4Epilepsy: An epilepsy gene resource , 2023, Epilepsia.

[3]  Javier de la Fuente,et al.  Pervasive Downward Bias in Estimates of Liability-Scale Heritability in Genome-wide Association Study Meta-analysis: A Simple Solution , 2022, Biological Psychiatry.

[4]  S. Gabriel,et al.  Rare coding variants in ten genes confer substantial risk for schizophrenia , 2022, Nature.

[5]  P. May,et al.  Distinct gene-set burden patterns underlie common generalized and focal epilepsies , 2021, EBioMedicine.

[6]  E. Tucker-Drob,et al.  Pervasive Downward Bias in Estimates of Liability Scale Heritability in GWAS Meta-Analysis: A Simple Solution , 2021, medRxiv.

[7]  Laurent F. Thomas,et al.  A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease , 2021, Nature Genetics.

[8]  M. Cairns,et al.  Advancing the use of genome-wide association studies for drug repurposing , 2021, Nature Reviews Genetics.

[9]  Ethan M. Goldberg,et al.  Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals. , 2021, American journal of human genetics.

[10]  U. Wieshmann,et al.  The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial , 2021, The Lancet.

[11]  Yi-wu Shi,et al.  RYR2 Mutations Are Associated With Benign Epilepsy of Childhood With Centrotemporal Spikes With or Without Arrhythmia , 2021, Frontiers in Neuroscience.

[12]  Hala Eweis,et al.  Celecoxib Decrease Seizures Susceptibility in a Rat Model of Inflammation by Inhibiting HMGB1 Translocation , 2021, Pharmaceuticals.

[13]  Ethan M. Goldberg,et al.  Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications , 2021, medRxiv.

[14]  Ewout J. N. Groen,et al.  Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology , 2021, Nature Genetics.

[15]  N. Waddell,et al.  Developing a gene panel for pharmacoresistant epilepsy: a review of epilepsy pharmacogenetics. , 2021, Pharmacogenomics.

[16]  Tom R. Gaunt,et al.  Brain expression quantitative trait locus and network 1 analysis reveals downstream effects and putative 2 drivers for brain-related diseases , 2021 .

[17]  S. Raychaudhuri,et al.  Accurate imputation of human leukocyte antigens with CookHLA , 2021, Nature Communications.

[18]  Laurent F. Thomas,et al.  Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles , 2021, Nature Genetics.

[19]  O. Delaneau,et al.  Efficient phasing and imputation of low-coverage sequencing data using large reference panels , 2020, Nature Genetics.

[20]  Jacob C. Ulirsch,et al.  Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases , 2020, Nature Genetics.

[21]  Buhm Han,et al.  HATK: HLA analysis toolkit , 2020, Bioinform..

[22]  M. Kanai,et al.  Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases , 2020, Nature Genetics.

[23]  E. Heinzen.  Somatic variants in epilepsy - advancing gene discovery and disease mechanisms. , 2020, Current opinion in genetics & development.

[24]  Lars G Fritsche,et al.  The emerging landscape of health research based on biobanks linked to electronic health records: Existing resources, statistical challenges, and potential opportunities , 2019, Statistics in medicine.

[25]  M. Daly,et al.  Polygenic burden in focal and generalized epilepsies , 2019, Brain : a journal of neurology.

[26]  Simon C. Potter,et al.  Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.

[27]  Doug Speed,et al.  Evaluating and improving heritability models using summary statistics , 2019, Nature Genetics.

[28]  J. Lupski,et al.  Biallelic CACNA2D2 variants in epileptic encephalopathy and cerebellar atrophy , 2019, Annals of clinical and translational neurology.

[29]  Ira M. Hall,et al.  Exome sequencing of Finnish isolates enhances rare-variant association power , 2019, Nature.

[30]  S. Smyth,et al.  Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy , 2019, Seizure.

[31]  Stuart J. Ritchie,et al.  Genomic SEM Provides Insights into the Multivariate Genetic Architecture of Complex Traits , 2019, Nature Human Behaviour.

[32]  Annie W Shieh,et al.  Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder , 2018, Science.

[33]  Prashant S. Emani,et al.  Comprehensive functional genomic resource and integrative model for the human brain , 2018, Science.

[34]  Christian Gieger,et al.  Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies , 2018, Nature Communications.

[35]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[36]  Gregory M. Cooper,et al.  CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..

[37]  Doug Speed,et al.  SumHer better estimates the SNP heritability of complex traits from summary statistics , 2018, Nature Genetics.

[38]  Luke R. Lloyd-Jones,et al.  Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes , 2018, Nature Communications.

[39]  Nick C Fox,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[40]  O. Andreassen,et al.  Beyond SNP heritability: Polygenicity and discoverability of phenotypes estimated with a univariate Gaussian mixture model , 2017, bioRxiv.

[41]  I. Scheffer,et al.  Epilepsy , 2018, Nature Reviews Disease Primers.

[42]  Jie Qiao,et al.  A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex , 2018, Nature.

[43]  N. Matsumoto,et al.  Identification of novel BCL11A variants in patients with epileptic encephalopathy: Expanding the phenotypic spectrum , 2018, Clinical genetics.

[44]  S. Djurovic,et al.  Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation , 2017, Nature Communications.

[45]  Patrick Kwan,et al.  Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study , 2017, JAMA neurology.

[46]  Liqing Du,et al.  Knockdown of RMI1 impairs DNA repair under DNA replication stress. , 2017, Biochemical and biophysical research communications.

[47]  D. Posthuma,et al.  Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.

[48]  P. Visscher,et al.  Multi-trait analysis of genome-wide association summary statistics using MTAG , 2017, Nature Genetics.

[49]  Lars G Fritsche,et al.  Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies , 2017, Nature Genetics.

[50]  Nicola J. Rinaldi,et al.  Genetic effects on gene expression across human tissues , 2017, Nature.

[51]  K. Rawlik,et al.  An atlas of genetic associations in UK Biobank , 2017, Nature Genetics.

[52]  L. Wilkins.  Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies , 2017, Neurology.

[53]  Saskia Freytag,et al.  brain-coX: investigating and visualising gene co-expression in seven human brain transcriptomic datasets , 2017, Genome Medicine.

[54]  Edouard Hirsch,et al.  ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.

[55]  Y. Kamatani,et al.  Overview of the BioBank Japan Project: Study design and profile , 2017, Journal of epidemiology.

[56]  M. Wood,et al.  Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein , 2017, Epilepsia.

[57]  D. Roelen,et al.  Anti‐LGI1 encephalitis is strongly associated with HLA‐DR7 and HLA‐DRB4 , 2017, Annals of neurology.

[58]  K. Chu,et al.  Anti‐LGI1 encephalitis is associated with unique HLA subtypes , 2017, Annals of neurology.

[59]  Michael R. Johnson,et al.  Ultra-rare genetic variation in common epilepsies: a case-control sequencing study , 2017, The Lancet Neurology.

[60]  Evan Z. Macosko,et al.  Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.

[61]  Tom R. Gaunt,et al.  LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.

[62]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[63]  I. Scheffer,et al.  The genetic landscape of the epileptic encephalopathies of infancy and childhood , 2016, The Lancet Neurology.

[64]  Po-Ru Loh,et al.  Fast and accurate long-range phasing in a UK Biobank cohort , 2015, Nature Genetics.

[65]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[66]  T. Lehtimäki,et al.  Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.

[67]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[68]  Joris M. Mooij,et al.  MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..

[69]  Bjarni V. Halldórsson,et al.  Large-scale whole-genome sequencing of the Icelandic population , 2015, Nature Genetics.

[70]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[71]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[72]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[73]  Michael R. Johnson,et al.  Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies , 2014, The Lancet Neurology.

[74]  Michael R. Johnson,et al.  Describing the genetic architecture of epilepsy through heritability analysis , 2014, Brain : a journal of neurology.

[75]  Stephen D. Turner,et al.  qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots , 2014, bioRxiv.

[76]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[77]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[78]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[79]  C. Gieger,et al.  Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. , 2012, Human molecular genetics.

[80]  Travis E. Nygard.  Chair , 2012 .

[81]  Nilanjan Chatterjee,et al.  A subset-based approach improves power and interpretation for the combined analysis of genetic association studies of heterogeneous traits. , 2012, American journal of human genetics.

[82]  Eleazar Eskin,et al.  Interpreting Meta-Analyses of Genome-Wide Association Studies , 2012, PLoS genetics.

[83]  Manolis Kellis,et al.  ChromHMM: automating chromatin-state discovery and characterization , 2012, Nature Methods.

[84]  Andrew P Morris,et al.  Meta-analysis of sex-specific genome-wide association studies , 2010, Genetic epidemiology.

[85]  S. Nattel,et al.  Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. , 2010, Journal of molecular and cellular cardiology.

[86]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[87]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[88]  Reedik Mägi,et al.  GWAMA: software for genome-wide association meta-analysis , 2010, BMC Bioinformatics.

[89]  Gonçalo R. Abecasis,et al.  Functional Gene Group Analysis Reveals a Role of Synaptic Heterotrimeric G Proteins in Cognitive Ability , 2010, American journal of human genetics.

[90]  Manuel A. R. Ferreira,et al.  Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.

[91]  Jing Shen,et al.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial , 2007, The Lancet.

[92]  Per Sidenius,et al.  Gender Differences in Epilepsy , 2005, Epilepsia.

[93]  B. Bourgeois.  Chronic Management of Seizures in the Syndromes of Idiopathic Generalized Epilepsy , 2003, Epilepsia.

[94]  V. Shkryl,et al.  Selective Blockade of N‐Type Calcium Channels by Levetiracetam , 2002, Epilepsia.

[95]  K. Hsu,et al.  Inhibition of N‐type calcium currents by lamotrigine in rat amygdalar neurones , 1996, Neuroreport.

[96]  OUP accepted manuscript , 2021, Brain Communications.

[97]  J. Engel,et al.  ILAE Official Report: A practical clinical definition of epilepsy , 2014, Epilepsia.

[98]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[99]  R. Maj,et al.  Safinamide , 2011, Neurotherapeutics.